| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| 5-(3'-Hydroxyphenyl)-γ-Valerolactone |
5-[(3-hydroxyphenyl)methyl]oxolan-2-one |
21618-91-7 |
詳細(xì)
|
| L202 |
|
2170488-92-1 |
詳細(xì)
|
| 1,2-Stearoyl-3-trimethylammoniumpropane (chloride) |
N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride |
220609-41-6 |
詳細(xì)
|
| Rp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt) |
RP-ADP-Α-S |
2005478-89-5 |
詳細(xì)
|
| Sp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt) |
SP-ADP-Α-S |
2005478-90-8 |
詳細(xì)
|
| 8-Bu(3-yne)T-NAD+ (sodium salt) |
|
2022926-15-2 |
詳細(xì)
|
| 8-bromo NAD+ (sodium salt) |
8-BROMO NICOTINAMIDE ADENINE DINUCLEOTIDE|||N(8-BROMO-A)D+ |
2022926-16-3 |
詳細(xì)
|
| 8-butylthio NAD+ (sodium salt) |
|
2022926-17-4 |
詳細(xì)
|
| 8-propylthio NAD+ (sodium salt) |
|
2022926-18-5 |
詳細(xì)
|
| PtdIns-(4,5)-P2 (1,2-dioctanoyl) |
1,2-十八酰磷酯酰肌醇-雙-4,5-磷酸 |
204858-53-7 |
詳細(xì)
|
| C12-SPM |
C12-SPM |
2055647-81-7 |
詳細(xì)
|
| Polymyxin E1 (sulfate) |
COLISTIN A SULFATE |
207990-63-4 |
詳細(xì)
|
| Phosmet-d6 |
亞胺硫磷-D6 |
2083623-41-8 |
詳細(xì)
|
| Lipid III-45 |
9-[(9-[(2-丁基辛酰基)氧基]壬基)(3-羥丙基)氨基]壬基2-丁基辛酸酯 |
2096984-25-5 |
詳細(xì)
|
| Eicosapentaenoyl-L-carnitine (chloride) |
|
2133456-02-5 |
詳細(xì)
|
| Cypermethrin-d5 |
|
2140327-50-8 |
詳細(xì)
|
| Acephate-d3 |
殺蟲靈-D3 |
2140327-70-2 |
詳細(xì)
|
| 4A3-SC8 |
4A3-SC8 |
1857340-78-3 |
詳細(xì)
|
| 1-Palmitoyl-d9-2-Arachidonoyl-sn-glycero-3-PC |
|
1872379-11-7 |
詳細(xì)
|
| 1,2-Dimyristoyl-3-trimethylammoniumpropane (chloride) |
1,2-二肉豆蔻酰基-3-三甲基銨 - 丙烷(氯化物鹽) |
197974-74-6 |
詳細(xì)
|
| cis-9-Heptadecenoic Acid |
9(Z)-十七碳烯酸 |
1981-50-6 |
詳細(xì)
|
| 2,3-dinor-8-iso Prostaglandin F1α |
2,3-DINOR-8-ISO PGF1Α|||2,3-DINOR-IPF1Α-III|||2,3-DINOR-5,6-DIHYDRO-15-F2T-ISOPROSTANE|||2,3-DINOR-5,6-DIHYDRO-15-F2T-ISOP |
221664-04-6 |
詳細(xì)
|
| Lipid 8 |
2-(二((9Z,12Z)-十八碳-9,12-二烯-1-基)氨基)乙基 4-(二甲基氨基)丁酸酯 |
2226547-25-5 |
詳細(xì)
|
| DNCA |
化合物 DNCA |
2226561-66-4 |
詳細(xì)
|
| Lipid 2,2(8,8) 4C CH3 |
ARCTURUS LIPID2(LIPID 2,2(8,8)4C CH3) |
2230647-30-8 |
詳細(xì)
|
| C14-SPM |
C14-SPM |
2241864-59-3 |
詳細(xì)
|
| Betamethasone-d5 |
|
2244574-92-1 |
詳細(xì)
|
| DXR Inhibitor 11a (free acid) |
1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE INHIBITOR 11A |
2260608-07-7 |
詳細(xì)
|
| Cardiolipin (14:1/14:1/14:1/14:1) (sodium salt) |
肉豆蔻烯酰心磷脂 |
2260669-33-6 |
詳細(xì)
|
| BSP-16 |
化合物 BSP16 |
2727249-47-8 |
詳細(xì)
|
| Ethoprop-d6 |
|
2733774-72-4 |
詳細(xì)
|
| Ambroxol-d5 (hydrochloride) |
|
2741380-71-0 |
詳細(xì)
|
| Cyclobenzaprine-d6 (hydrochloride) |
|
2748492-38-6 |
詳細(xì)
|
| BHD |
化合物 BHD |
2749517-98-2 |
詳細(xì)
|
| SLU-10482 |
化合物 SLU-10482 |
2755451-45-5 |
詳細(xì)
|
| YK-009 |
|
2761458-86-8 |
詳細(xì)
|
| Fz25 |
|
2762498-70-2 |
詳細(xì)
|
| CL4F8-6 |
化合物 CL4F8-6 |
2766493-12-1 |
詳細(xì)
|
| Tauro-Obeticholic Acid (sodium salt) |
TAURO-6-ETHYLCHENODEOXYCHOLIC ACID|||TAURO-6-ETHYL-CDCA|||OBETICHOLIC ACID TAURINE CONJUGATE|||TAURO-OCA|||T-ECDCA |
2278141-79-8 |
詳細(xì)
|
| S-Geranylgeranyl-L-glutathione |
GGG |
2364639-42-7 |
詳細(xì)
|
| CT3 |
化合物 TOPOISOMERASE II INHIBITOR 16 |
2403729-27-9 |
詳細(xì)
|
| 11-A-M |
化合物 LNP LIPID-8 |
2408140-60-1 |
詳細(xì)
|
| A12-Iso5-2DC18 |
A12-LSO5-2DC12 |
2412492-06-7 |
詳細(xì)
|
| Lipid 10 |
2-(二((9Z,12Z)-十八碳-9,12-二烯-1-基)氨基)乙基 3-(4-甲基哌嗪-1-基)丙酸酯 |
2430034-02-7 |
詳細(xì)
|
| Lipid 14 |
化合物 LIPID 14 |
2430034-05-0 |
詳細(xì)
|
| ALC-0315 analogous-1 |
8-[(8-[(2-己基癸?；?氧基]辛基)(2-羥乙基)氨基]辛基-2-己基癸酸酯 |
2430034-17-4 |
詳細(xì)
|
| S-72 |
化合物 S-72 |
2446799-14-8 |
詳細(xì)
|
| Biotin-Cholesterol |
化合物 BIOTIN-CHOLESTEROL |
2454045-15-7 |
詳細(xì)
|
| Pyridaben-d13 |
|
2468638-05-1 |
詳細(xì)
|
| Spirotetramat-d5 |
|
2469007-09-6 |
詳細(xì)
|
| Oxamyl-d6 |
|
2470229-60-6 |
詳細(xì)
|
| SGC-CK2-1 |
丙酰胺,N-[5-[[3-氰基-7-(環(huán)丙基氨基)吡唑并[1,5-A]嘧啶-5-基]氨基]-2-甲基苯基]- |
2470424-39-4 |
詳細(xì)
|
| Flonicamid-15N,18O |
|
2483830-60-8 |
詳細(xì)
|
| Cyfluthrin-d6 |
氟氯氰菊酯,混合立體異構(gòu)體(化學(xué)。純度95%) |
2483831-11-2 |
詳細(xì)
|
| Ferroptocide |
化合物 FERROPTOCIDE |
2505218-38-0 |
詳細(xì)
|
| Tauro-d4-ursodeoxycholic Acid |
|
2573035-17-1 |
詳細(xì)
|
| Z-CITCO |
化合物 Z-CITCO |
2583138-04-7 |
詳細(xì)
|
| Griselimycin |
RP-11072-B|||RP11072-B|||RP 11072-B|||GRISELLIMYCIN B |
26034-16-2 |
詳細(xì)
|
| 9-keto Tafluprost |
|
261179-75-3 |
詳細(xì)
|
| Lipid A4 |
|
2639634-71-0 |
詳細(xì)
|
| C14-4 |
1,1′-[[2-[2-[4-[2-[[2-[2-[雙(2-羥基十四烷基)氨基]乙氧基]乙基](2-羥基十四烷基)氨基]乙基]-1-哌嗪基]乙氧基]乙基]亞氨基]雙[2-十四烷醇 |
2639634-80-1 |
詳細(xì)
|
| AMX12006 |
化合物 AMX12006 |
2639775-01-0 |
詳細(xì)
|
| Adenosine 5'-methylenediphosphate (sodium salt) |
|
2659222-76-9 |
詳細(xì)
|
| C18 Ganglioside GM3-d3 (d18:1/18:0-d3) (ammonium salt, synthetic) |
|
2692623-85-9 |
詳細(xì)
|
| CoPoP |
化合物 COPOP |
2805223-60-1 |
詳細(xì)
|
| SM-102 N-oxide |
|
2824195-50-6 |
詳細(xì)
|
| STING Agonist D61 |
D61|||STIMULATOR OF INTERFERON GENES AGONIST D61 |
2850251-27-1 |
詳細(xì)
|
| DRB18 |
化合物DRB18 |
2863686-81-9 |
詳細(xì)
|
| DC-LC3in-D5 |
化合物 DC-LC3IN-D5 |
2868312-73-4 |
詳細(xì)
|
| JAK Inhibitor 31 |
化合物 JAK-IN-30 |
2891469-99-9 |
詳細(xì)
|
| Dopamine D3 Receptor Agonist 13a |
化合物 DOPAMINE D3 RECEPTOR AGONIST 13A |
2899250-94-1 |
詳細(xì)
|
| STING Agonist 12L |
STIMULATOR OF INTERFERON GENES AGONIST 12L |
2913152-30-2 |
詳細(xì)
|
| C18 |
GPX4 抑制劑 5 |
2922824-09-5 |
詳細(xì)
|
| MTDB-Alkyne |
|
2923694-73-7 |
詳細(xì)
|
| UNC8153 (trifluoroacetate salt) |
UNC8153 三氟乙酸鹽 |
2929304-61-8 |
詳細(xì)
|
| RM 133-3 |
化合物 MR-2-93-3 |
2941228-90-4 |
詳細(xì)
|
| RCB-4-8 |
化合物 RCB-02-4-8 |
2941228-91-5 |
詳細(xì)
|
| 4-(Acetyloxy)-N,N-dimethyl-α-oxo-1H-indole-3-acetamide |
3-(2-(二甲基氨基)-2-氧代乙酰基)-1H-吲哚-4-基乙酸酯 |
30000-66-9 |
詳細(xì)
|
| Oleoyl-L-carnitine (chloride) |
油?；?L-肉毒堿 鹽酸鹽 |
31062-78-9 |
詳細(xì)
|
| 1,2-Dihexanoyl-sn-glycero-3-PS (sodium salt) |
1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHO-L-SERINE (SODIUM SALT);06:0 PS |
321862-85-5 |
詳細(xì)
|
| 1,2-Dioleoyl-3(R)-trimethylammoniumpropane (chloride) |
|
328250-28-8 |
詳細(xì)
|
| Malathion-d10 |
氘代馬拉硫磷 |
347841-48-9 |
詳細(xì)
|
| (±)16,17-EDT |
(±)16,17-EPOXYDOCOSATRIENOIC ACID|||(±)-DIHOMO-16,17-EET|||(±)16,17-EPDOTRE |
351533-79-4 |
詳細(xì)
|
| 17β-Estradiol-2,4,16,16-d4 3-sulfate (sodium salt) |
SODIUM 17BETA-ESTRADIOL-2,4,16,16-D4 3-SULFATE |
352431-50-6 |
詳細(xì)
|
| (±)13,14-EDT |
(±)13,14-EPOXYDOCOSATRIENOIC ACID|||(±)13,14-EPDOTRE|||(±)-DIHOMO-13,14-EET |
355016-19-2 |
詳細(xì)
|
| (±)10,11-EDT |
|
355016-20-5 |
詳細(xì)
|
| (±)7(S),8(R)-EDT |
|
355016-21-6 |
詳細(xì)
|
| Purine riboside-5'-O-triphosphate (sodium salt) |
|
35892-95-6 |
詳細(xì)
|
| SZM-1209 |
化合物 SZM-1209 |
2919801-86-6 |
詳細(xì)
|
| UCL-TRO-1938 |
1-(7-((2-((4-(4-乙基哌嗪-1-基)苯基)氨基)吡啶-4-基)氨基)吲哚啉-1-基)乙酮 |
2919575-27-0 |
詳細(xì)
|
| Spiromesifen-d9 |
Spiromesifen-d9 |
2470126-90-8 |
詳細(xì)
|
| Acequinocyl-d25 |
|
2469735-25-7 |
詳細(xì)
|
| Spiroxamine-d4 |
|
2469272-82-8 |
詳細(xì)
|
| Fenoxycarb-d3 |
Fenoxycarb-d3 |
2468639-22-5 |
詳細(xì)
|
| DOG-IM4 |
化合物 DOG-IM4 |
2758097-38-8 |
詳細(xì)
|
| Lipid AX4 |
化合物 LIPID AX4 |
2735814-23-8 |
詳細(xì)
|
| C16 dihydro Ceramide-d9 (d18:0/16:0-d9) |
|
2260669-52-9 |
詳細(xì)
|
| POMHEX |
化合物POMHEX |
2004714-34-3 |
詳細(xì)
|
| Cyano-myracrylamide |
|
2801702-34-9 |
詳細(xì)
|
| Fluostatin A (sodium salt) |
化合物 FLUOSTATIN A SODIUM |
209673-93-8 |
詳細(xì)
|